{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T10:17:27Z","timestamp":1767694647855,"version":"3.48.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Methicillin-resistant Staphylococcus aureus (MRSA) is a common pathogen in burn-injured patients. Many studies have evaluated the overall utility of MRSA nares polymerase chain reaction (PCR) swabs for antimicrobial stewardship; however, there is a paucity of data in burns. This study evaluated the clinical utility of MRSA PCR in burn-injured patients at an academic medical center. This retrospective, single-center chart review included admitted adult burn-injured patients from July 2020 to June 2024. The primary objective was to determine the overall negative predictive value (NPV) of MRSA PCR in patients with burn injuries for suspected MRSA infections. Secondary objectives included determining the sensitivity, specificity, NPV, and positive predictive value (PPV) of MRSA PCR for specific culture types. There were 89 patients, and 289 cultures were included. The overall prevalence of MRSA positive cultures was 13.4% for the study period. For the primary outcome, the NPV of MRSA PCR was 98.3% (95% confidence interval, 95.5%-99.5%). For the whole cohort the PPV was 22.5%, sensitivity was 73.4%, and specificity was 86.1%. The total cost of vancomycin therapy (doses and levels) was US $37\u2009935.75, which was estimated using average wholesale price. A cost avoidance of US $378.15 per patient was estimated for patients not meeting criteria for vancomycin therapy. Overall, this study found a high NPV for MRSA PCR in burn-injured patients with suspected infections. In addition, MRSA PCR may be used along with other clinical markers to decrease the use of antimicrobials targeting MRSA, which may help decrease the cost of therapy.<\/jats:p>","DOI":"10.1093\/jbcr\/iraf120","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:56:08Z","timestamp":1751608568000},"page":"160-166","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Utility of Methicillin-Resistant\n                    <i>Staphylococcus aureus<\/i>\n                    Polymerase Chain Reaction Nares Swabs in Burn-Injured Patients"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4868-3612","authenticated-orcid":false,"given":"Jade","family":"Montgomery","sequence":"first","affiliation":[{"name":"South Carolina Burn Center, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]},{"name":"Department of Pharmacy, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Burgoon","sequence":"additional","affiliation":[{"name":"South Carolina Burn Center, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]},{"name":"Department of Pharmacy, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Hamby","sequence":"additional","affiliation":[{"name":"South Carolina Burn Center, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]},{"name":"Department of Pharmacy, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie Smith","family":"Condeni","sequence":"additional","affiliation":[{"name":"South Carolina Burn Center, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]},{"name":"Department of Pharmacy, Medical University of South Carolina , Charleston, SC 29425 ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"2026010605123568900_ref1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.burns.2016.08.013","article-title":"Recent trends in burn epidemiology worldwide: a systematic review","volume":"43","author":"Smolle","year":"2017","journal-title":"Burns"},{"article-title":"Burns","year":"2025","author":"WHO","key":"2026010605123568900_ref2"},{"key":"2026010605123568900_ref3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/sur.2013.134","article-title":"Infection in burns","volume":"17","author":"Norbury","year":"2016","journal-title":"Surg Infect"},{"key":"2026010605123568900_ref4","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.burns.2008.02.010","article-title":"Mortality and causes of death in a burn centre","volume":"34","author":"Bloemsma","year":"2008","journal-title":"Burns"},{"key":"2026010605123568900_ref5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/sur.2020.129","article-title":"Multi-drug-resistant organisms in burn infections","volume":"22","author":"Robben","year":"2021","journal-title":"Surg Infect"},{"key":"2026010605123568900_ref6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4266\/acc.2023.01571","article-title":"Microbial infections in burn patients","volume":"39","author":"Roy","year":"2024","journal-title":"ACC"},{"key":"2026010605123568900_ref7","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/jbcr\/irae075","article-title":"Multidrug-resistant organisms: the silent plight of burn patients","volume":"45","author":"Elsheikh","year":"2024","journal-title":"J Burn Care Res"},{"key":"2026010605123568900_ref8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1177\/10600280211023209","article-title":"Impact of prior-to-admission methicillin-resistant Staphylococcus aureus nares screening in critically ill adults with pneumonia","volume":"56","author":"Mallidi","year":"2022","journal-title":"Ann Pharmacother"},{"key":"2026010605123568900_ref9","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1177\/10600280221145152","article-title":"Comparison of methicillin-resistant Staphylococcus aureus nasal screening predictive value in the intensive care unit and general ward","volume":"57","author":"Buckley","year":"2023","journal-title":"Ann Pharmacother"},{"key":"2026010605123568900_ref10","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2147\/IDR.S351832","article-title":"Evaluation of the negative predictive value of methicillin-resistant Staphylococcus aureus nasal swab screening in the medical intensive care units and its effect on antibiotic duration","volume":"15","author":"Tai","year":"2022","journal-title":"Infect Drug Resist"},{"key":"2026010605123568900_ref11","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/003655400459478","article-title":"Spread of Staphylococcus aureus in hospitals: causes and prevention","volume":"32","author":"Solberg","year":"2000","journal-title":"Scand J Infect Dis"},{"volume-title":"Methicillin-resistant Staphylococcus aureus (MRSA). Clinical overview of methicillin-resistant Staphylococcus aureus (MRSA) in healthcare settings","year":"2024","author":"CDC","key":"2026010605123568900_ref12"},{"key":"2026010605123568900_ref13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13756-023-01210-6","article-title":"The global prevalence of methicillin-resistant Staphylococcus aureus colonization in residents of elderly care centers: a systematic review and meta-analysis","volume":"12","author":"Hasanpour","year":"2023","journal-title":"Antimicrob Resist Infect Control"},{"key":"2026010605123568900_ref14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.burns.2017.01.009","article-title":"Screening nasal swabs for methicillin resistant Staphylococcus aureus: a regional burn center\u2019s experience","volume":"43","author":"Tejiram","year":"2017","journal-title":"Burns"},{"key":"2026010605123568900_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.burns.2024.08.025","article-title":"Predictive values of methicillin-resistant Staphylococcus aureus nasal swabs for pneumonia in burn ICU patients","volume":"50","author":"Carlson","year":"2024","journal-title":"Burns"},{"key":"2026010605123568900_ref16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.18683\/germs.2018.1138","article-title":"Incidence of methicillin resistant Staphylococcus aureus (MRSA) in burn intensive care unit: a systematic review","volume":"8","author":"Khan","year":"2018","journal-title":"Germs"},{"key":"2026010605123568900_ref17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.ajic.2021.12.005","article-title":"Clinical utility of negative methicillin-resistant Staphylococcus aureus (MRSA) nasal surveillance swabs in skin and skin structure infections","volume":"50","author":"Burgoon","year":"2022","journal-title":"Am J Infect Control"},{"key":"2026010605123568900_ref18","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.burns.2019.02.023","article-title":"The relation between positive screening results and MRSA infections in burn patients","volume":"45","author":"Pangli","year":"2019","journal-title":"Burns"},{"key":"2026010605123568900_ref19","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.burns.2019.05.014","article-title":"MRSA colonization and acquisition in the burn unit: a systematic review and meta-analysis","volume":"45","author":"Kalligeros","year":"2019","journal-title":"Burns"},{"key":"2026010605123568900_ref20","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1093\/ajhp\/zxab109","article-title":"Evaluation of the timing of MRSA PCR nasal screening: how long can a negative assay be used to rule out MRSA-positive respiratory cultures?","volume":"78","author":"Turner","year":"2021","journal-title":"Am J Health Syst Pharm"},{"key":"2026010605123568900_ref21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1177\/1060028018823027","article-title":"Systematic review of the clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening for MRSA pneumonia","volume":"53","author":"Smith","year":"2019","journal-title":"Ann Pharmacother"},{"key":"2026010605123568900_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2021.115389","article-title":"Correlation of MRSA polymerase chain reaction (PCR) wound swab testing and wound cultures in skin and soft tissue infections","volume":"100","author":"Clay","year":"2021","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026010605123568900_ref23","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jcrc.2016.11.008","article-title":"Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction assay in critically ill patients with nosocomial pneumonia","volume":"38","author":"Smith","year":"2017","journal-title":"J Crit Care"},{"key":"2026010605123568900_ref24","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/cid\/ciz974","article-title":"Determining the utility of methicillin-resistant Staphylococcus aureus nares screening in antimicrobial stewardship","volume":"71","author":"Mergenhagen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2026010605123568900_ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1574-695X.2009.00565.x","article-title":"The role of nasal carriage in Staphylococcus aureus burn wound colonization","volume":"57","author":"Kooistra-Smid","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"2026010605123568900_ref26","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.burns.2023.08.021","article-title":"Patterns of antibiotic administration in patients with burn injuries: a TriNetX study","volume":"50","author":"Wermine","year":"2024","journal-title":"Burns"},{"volume-title":"Vancomycin (Lexi-Drugs)\u2014UpToDate\u00ae Lexidrug\u2122","year":"2025","key":"2026010605123568900_ref27"},{"volume-title":"Doxycycline (Lexi-Drugs)\u2014UpToDate\u00ae Lexidrug\u2122","year":"2025","key":"2026010605123568900_ref28"},{"volume-title":"Sulfamethoxazole and Trimethoprim (Lexi-Drugs)\u2014UpToDate\u00ae Lexidrug\u2122","year":"2025","key":"2026010605123568900_ref29"},{"volume-title":"DAPTOmycin (Lexi-Drugs)\u2014UpToDate\u00ae Lexidrug\u2122","year":"2025","key":"2026010605123568900_ref30"},{"volume-title":"Linezolid (Lexi-Drugs)\u2014UpToDate\u00ae Lexidrug\u2122","year":"2025","key":"2026010605123568900_ref31"},{"key":"2026010605123568900_ref32","doi-asserted-by":"crossref","first-page":"107259","DOI":"10.1016\/j.burns.2024.08.025","article-title":"Predictive values of methicillin-resistant Staphylococcus aureus nasal swabs for pneumonia in burn ICU patients","volume":"50","author":"Carlson","year":"2024","journal-title":"Burns"},{"key":"2026010605123568900_ref33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciy024","article-title":"The clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications","volume":"67","author":"Parente","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2026010605123568900_ref34","doi-asserted-by":"publisher","first-page":"100764","DOI":"10.1016\/j.nmni.2020.100764","article-title":"Epidemiology of burn wound bacterial infections at a Meknes hospital","volume":"38","author":"El Hamzaoui","year":"2020","journal-title":"Morocco New Microbes New Infect"},{"key":"2026010605123568900_ref35","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2022.256","article-title":"Clinical utility of methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction (PCR) assays beyond respiratory infections","volume":"2","author":"Noeldner","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026010605123568900_ref36","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/phar.2188","article-title":"Clinical utility of methicillin-resistant Staphylococcus aureus nasal screening for antimicrobial stewardship: a review of current literature","volume":"38","author":"Carr","year":"2018","journal-title":"Pharmacotherapy"},{"key":"2026010605123568900_ref37","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1128\/AAC.01751-16","article-title":"Using MRSA screening tests to predict methicillin resistance in Staphylococcus aureus bacteremia","volume":"60","author":"Butler-Laporte","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026010605123568900_ref38","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1542\/hpeds.2023-007614","article-title":"Methicillin-resistant Staphylococcus aureus surveillance testing: more than meets the nare","volume":"14","author":"Symons","year":"2024","journal-title":"Hospital Pediatrics"},{"key":"2026010605123568900_ref39","doi-asserted-by":"publisher","first-page":"ofab099","DOI":"10.1093\/ofid\/ofab099","article-title":"Discontinuation patterns and cost avoidance of a pharmacist-driven methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction testing protocol for de-escalation of empiric vancomycin for suspected pneumonia","volume":"8","author":"Meng","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2026010605123568900_ref40","doi-asserted-by":"publisher","first-page":"e194","DOI":"10.1097\/BCR.0000000000000120","article-title":"Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review","volume":"36","author":"Steele","year":"2015","journal-title":"J Burn Care Res"}],"container-title":["Journal of Burn Care &amp; Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbcr\/advance-article-pdf\/doi\/10.1093\/jbcr\/iraf120\/63668095\/iraf120.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/47\/1\/160\/63668095\/iraf120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbcr\/article-pdf\/47\/1\/160\/63668095\/iraf120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T10:12:43Z","timestamp":1767694363000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbcr\/article\/47\/1\/160\/8185782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7,4]]},"published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jbcr\/iraf120","relation":{},"ISSN":["1559-047X","1559-0488"],"issn-type":[{"type":"print","value":"1559-047X"},{"type":"electronic","value":"1559-0488"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,7,4]]}}}